Statement Of Cash Flows

Kohjin Bio Co., Ltd. - Filing #7341060

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
922,994,000 JPY
1,104,946,000 JPY
Interest and dividends received
641,000 JPY
490,000 JPY
Interest paid
-32,434,000 JPY
-40,543,000 JPY
Income taxes paid
-430,048,000 JPY
-301,912,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Net cash provided by (used in) operating activities
461,153,000 JPY
762,981,000 JPY
Cash flows from investing activities
Purchase of securities
-9,999,000 JPY
JPY
Purchase of property, plant and equipment
-560,664,000 JPY
-202,642,000 JPY
Proceeds from sale of property, plant and equipment
JPY
1,280,000 JPY
Net cash provided by (used in) investing activities
-575,459,000 JPY
82,780,000 JPY
Loan advances
-7,000,000 JPY
JPY
Proceeds from collection of loans receivable
7,000,000 JPY
JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Proceeds from issuance of shares
JPY
58,500,000 JPY
Proceeds from short-term borrowings
600,000,000 JPY
300,000,000 JPY
Repayments of short-term borrowings
-300,000,000 JPY
JPY
Dividends paid
-41,650,000 JPY
-33,850,000 JPY
Repayments of long-term borrowings
-409,600,000 JPY
-661,600,000 JPY
Net cash provided by (used in) financing activities
-172,209,000 JPY
-360,174,000 JPY
Effect of exchange rate change on cash and cash equivalents
14,593,000 JPY
29,205,000 JPY
Net increase (decrease) in cash and cash equivalents
-271,921,000 JPY
514,791,000 JPY
Cash and cash equivalents
1,462,566,000 JPY
1,734,488,000 JPY
1,219,697,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.